Treatment of posterior capsule opacification

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/50 (2006.01) A61K 9/00 (2006.01) A61K 31/00 (2006.01) A61K 31/155 (2006.01) A61K 31/439 (2006.01) A61K 31/496 (2006.01)

Patent

CA 2578117

The invention relates to a method of testing agents, such as sigma ligands for their potential use in treating posterior capsule opacification (PCO). The present invention also relates to the use of sigma ligands, such as sigma-1 antagonists in the manufacture of a medicament for preventing posterior capsule opacification (PCO), as well as methods of treating PCO using sigma ligands.

L'invention concerne un procédé d'essai d'agents, de type ligands sigma, pour leur utilisation potentielle dans le traitement de l'opacification de la capsule postérieure (PCO). L'invention concerne également l'utilisation de ligands sigma, de type antagonistes sigma-1, dans la production d'un médicament pour la prévention de l'opacification de la capsule postérieure (PCO), ainsi que des méthodes de traitement de l'opacification de la capsule postérieure (PCO) au moyen des ligands sigma.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of posterior capsule opacification does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of posterior capsule opacification, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of posterior capsule opacification will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1385180

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.